BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Y, Si X, Yang L, Wang H, Sun Y, Liu N. Association between intestinal microbiota and inflammatory bowel disease. Animal Model Exp Med 2022. [PMID: 35808814 DOI: 10.1002/ame2.12255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 So D, Quigley EMM, Whelan K. Probiotics in irritable bowel syndrome and inflammatory bowel disease: review of mechanisms and effectiveness. Curr Opin Gastroenterol 2023;39:103-9. [PMID: 36821458 DOI: 10.1097/MOG.0000000000000902] [Reference Citation Analysis]
2 Zhu M, Xu H, Liang Y, Xu J, Yue N, Zhang Y, Tian C, Yao J, Wang L, Nie Y, Li D. Edible exosome-like nanoparticles from Portulaca oleracea L prevent DSS-induced colitis via the promotion of double-positive CD4 + CD8 + T cells.. [DOI: 10.21203/rs.3.rs-2439295/v1] [Reference Citation Analysis]
3 Schwarz A, Philippsen R, Piticchio SG, Hartmann JN, Häsler R, Rose-John S, Schwarz T. Crosstalk between microbiome, regulatory T cells and HCA2 orchestrates the inflammatory response in a murine psoriasis model. Front Immunol 2023;14:1038689. [PMID: 36891315 DOI: 10.3389/fimmu.2023.1038689] [Reference Citation Analysis]
4 Sun J, Chen W, Yuan Z. Characterization of Intestinal Microbiota in Lambs with Different Susceptibility to Escherichia coli F17. Vet Sci 2022;9. [PMID: 36548832 DOI: 10.3390/vetsci9120670] [Reference Citation Analysis]
5 Michalak A, Kasztelan-szczerbińska B, Cichoż-lach H. Impact of Obesity on the Course of Management of Inflammatory Bowel Disease—A Review. Nutrients 2022;14:3983. [DOI: 10.3390/nu14193983] [Reference Citation Analysis]